Scarica l'app Stockscreener
6.56
1.23%
0.08
Pre-mercato:
6.56
Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie
(LFCR) Technical Data - Stock Traders Daily
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Sees Significant Increase in Short Interest - Defense World
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Short Interest Update - MarketBeat
Lifecore Biomedical Announces Special Stockholder Meeting - The Manila Times
Lifecore Biomedical Calls Special Meeting to Vote on Preferred Stock Conversion Cap Removal - StockTitan
Jane Street Group LLC Increases Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - AccessWire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - AccessWire
LFCR FY2025 EPS Forecast Boosted by Barrington Research - Defense World
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - AccessWire
LFCR FY2025 EPS Forecast Lifted by Barrington Research - MarketBeat
Paul Josephs Bought 3.1% More Shares In Lifecore Biomedical - Simply Wall St
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire
Lifecore Biomedical, Inc. (NASDAQ:LFCR) CEO Paul Josephs Acquires 17,000 Shares - MarketBeat
Geode Capital Management LLC Increases Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Barclays PLC Has $147,000 Stock Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Lifecore Biomedical to sell multi-purpose 10-head isolator filler - MSN
Lifecore Biomedical Sells Excess Capital Equipment for $17M - Contract Pharma
Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million - The Manila Times
Lifecore Biomedical Secures $17M Equipment Sale, Doubles Production Capacity with New Filler - StockTitan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - AccessWire
Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
LFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into Lifecore Biomedical, Inc. and Encourages Investors to Contact the Firm - AccessWire
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q2 2025 Earnings Call Transcript - MSN
Lifecore Biomedical’s (LFCR) “Equal Weight” Rating Reaffirmed at Stephens - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out - AccessWire
Lifecore stock reaffirmed at Equal Weight at Stephens following Q2 results By Investing.com - Investing.com Canada
Lifecore Biomedical's (LFCR) "Equal Weight" Rating Reaffirmed at Stephens - MarketBeat
Further weakness as Lifecore Biomedical (NASDAQ:LFCR) drops 11% this week, taking three-year losses to 38% - Simply Wall St
US Stocks Poised To Open Higher As Futures Advance: Tesla, Bumble, Lifecore Bio In Focus - Benzinga
Lifecore Biomedical: Fiscal Q2 Earnings Snapshot - Midland Daily News
Lifecore Biomedical earnings beat by $0.02, revenue topped estimates - Investing.com UK
Resources Connection, SPS Commerce And 3 Stocks To Watch Heading Into Friday - Benzinga
Lifecore Biomedical Inc (LFCR) Q2 2025 Earnings Call Highlights: Revenue Growth Amidst Rising ... By GuruFocus - Investing.com Canada
Earnings call transcript: Lifecore Biomedical Q2 2024 sees revenue growth, stock dips - Investing.com Australia
Lifecore Biomedical Reports Q2 Fiscal 2025 Results - TipRanks
Lifecore Biomedical Inc (LFCR) Q2 Fiscal 2025 Earnings: EPS Loss - GuruFocus.com
Lifecore Biomedical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 24, 2024 - Marketscreener.com
Lifecore Biomedical (LFCR) Reports Q2 Loss, Tops Revenue Estimates - MSN
Stocks to Watch: Lifecore Biomedical, Resources Connection - MarketWatch
Lifecore Biomedical Inc. (LFCR) reports earnings - Quartz
Lifecore Biomedical (NASDAQ:LFCR) Issues Earnings Results - MarketBeat
Lifecore Biomedical Swings to 2Q Loss Despite Higher Sales - MarketWatch
Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update - The Manila Times
Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate - The Bakersfield Californian
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Acquired by State Street Corp - Defense World
Earnings To Watch: Lifecore Biomedical Inc (LFCR) Reports Q2 202 - GuruFocus.com
Earnings To Watch: Lifecore Biomedical Inc (LFCR) Reports Q2 2025 Result - Yahoo Finance
2.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):